Efficiency of citicoline in the therapy of cognitive and motor disorders in patients in the early recovery period of stroke
The article presents a critical review of studies of citicoline in the treatment of cognitive disorders after stroke and chronic cerebral ischemia, as well as in the treatment of post-stroke motor disorders in the early recovery period after acute cerebrovascular events. The results of these studies indicate that citicoLine can be considered one of the most studied neuroprotective drugs. Due to the fact that citicoline can affect different stages of ischemic damage in clinical practice the drug shows effect in acute stroke and in the rehabilitation phase, thus stimulating the recovery of both cognitive and motor functions.